Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low? (Q42993103)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2009
edit
Language Label Description Also known as
English
Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?
scientific article published in September 2009

    Statements

    Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low? (English)
    Ahmet Danalioglu

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit